IKBKG

Across TCGA pan-cancer cohorts, IKBKG mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of IKBKG’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where IKBKG mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types IKBKG is over-expressed in tumor, although a few such as COAD and LSCC show the opposite, repressed pattern.

CCRCC, PDAC, and COAD are the cancer types where IKBKG tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IKBKG mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	II,III,IV	+0.326	<.001	12	view →
PDAC	Female	All	+0.349	<.001	6	view →
COAD	All	All	−0.101	<.001	6	view →
LSCC	All	II,III,IV	−0.090	.002	4	view →
HNSC	All	II,III,IV	+0.062	.048	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

IKBKG–CCRCC

Open the CCRCC breakdown →